The shift is coming. The FDA recognizes that “compliance only” has not had the intended consequences. Recalls are on the rise, and quality risk is accelerating as product complexity and change accelerate. Leading medical device manufacturers are anticipating that shift, and have invested in a culture focused on product quality.
This white paper outlines the business value of focusing on quality rather than compliance, and the technology infrastructures required to close the loop on product quality.